Skip to content

Menu

Arnold & Porter Kaye Scholer LLP logo
HomeAboutServicesContact

BioSlice Blog

legacy devices

Subscribe to legacy devices

EU MDR implementation: new guidance and implications of the deferral

By Jackie Mulryne, Louise Strom & Eftychia Sideri on May 6, 2020
Posted in European Commission, MDR, Medical Devices

As part of our series of blog posts covering the implementation of the EU Medical Devices Regulation (MDR), we comment below on the latest developments, including the deferred application of the MDR and the most recent guidance issued by the European Commission’s medical device coordination group (MDCG).
Continue Reading EU MDR implementation: new guidance and implications of the deferral

Providing timely updates and commentary on legal and regulatory developments to the European life sciences community and beyond.

Read More....
Twitter Facebook LinkedIn

Topics

Archives

BioSlice Blog

Arnold & Porter Kaye Scholer LLP logo
Twitter Facebook LinkedIn
DisclaimerPrivacy Policy

With nearly 1,000 lawyers practicing in 14 offices around the globe, Arnold & Porter serves clients across 40 distinct practice areas. The firm offers 100 years of renowned regulatory expertise, sophisticated litigation and transactional practices, and leading multidisciplinary offerings in the life sciences and financial services industries.

Copyright © 2023, Arnold & Porter Kaye Scholer LLP All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo